HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Vicente Valero Selected Research
Vicente Valero Research Topics
Disease
189
Breast Neoplasms (Breast Cancer)
02/2022 - 01/2002
117
Neoplasms (Cancer)
01/2022 - 04/2002
41
Pathologic Complete Response
12/2022 - 06/2002
20
Triple Negative Breast Neoplasms
12/2022 - 09/2008
20
Inflammatory Breast Neoplasms
12/2021 - 08/2005
20
Neoplasm Metastasis (Metastasis)
11/2018 - 07/2002
10
Disease Progression
12/2018 - 04/2002
9
Residual Neoplasm
01/2022 - 01/2007
7
Cardiotoxicity
02/2022 - 11/2002
7
Fatigue
12/2021 - 02/2004
6
Carcinoma (Carcinomatosis)
10/2013 - 06/2005
5
Neutropenia
01/2021 - 02/2013
5
Circulating Neoplastic Cells
01/2020 - 07/2009
5
Fistula
01/2019 - 02/2016
4
Heart Failure
09/2019 - 11/2002
4
Pancreatic Fistula (Pancreatic Fistulas)
01/2019 - 02/2016
4
Lymphatic Metastasis
04/2016 - 03/2006
4
Lacrimal Apparatus Diseases (Epiphora)
06/2013 - 06/2002
4
Pathologic Constriction (Stenosis)
06/2013 - 06/2002
3
Noninfiltrating Intraductal Carcinoma (DCIS)
08/2019 - 11/2005
3
Febrile Neutropenia
01/2018 - 01/2011
3
Infections
02/2016 - 01/2006
3
Thrombocytopenia (Thrombopenia)
01/2011 - 07/2002
2
Left Ventricular Dysfunction
02/2022 - 11/2005
2
Brain Neoplasms (Brain Tumor)
03/2021 - 09/2006
2
Sepsis (Septicemia)
01/2021 - 04/2015
2
Fever (Fevers)
01/2021 - 07/2003
2
Necrosis
01/2021 - 01/2017
2
Frailty
03/2020 - 02/2015
2
Body Weight (Weight, Body)
03/2020 - 04/2007
2
Peripheral Nervous System Diseases (PNS Diseases)
01/2020 - 02/2013
2
Margins of Excision
04/2018 - 02/2003
2
Stroke (Strokes)
01/2018 - 06/2015
2
Adenocarcinoma
12/2016 - 09/2014
2
Renal Insufficiency (Renal Failure)
06/2015 - 01/2015
Drug/Important Bio-Agent (IBA)
31
Trastuzumab (Herceptin)
FDA Link
02/2022 - 04/2002
30
Estrogen Receptors
IBA
10/2021 - 05/2002
29
Anthracyclines
IBA
01/2022 - 04/2002
27
Hormones (Hormone)
IBA
01/2022 - 09/2004
24
Docetaxel (Taxotere)
FDA Link
01/2019 - 01/2002
22
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2022 - 06/2002
21
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022 - 06/2002
18
Paclitaxel (Taxol)
FDA Link
Generic
02/2022 - 05/2002
18
taxane
IBA
01/2021 - 03/2003
15
Biomarkers (Surrogate Marker)
IBA
01/2022 - 03/2005
15
human ERBB2 protein
IBA
12/2021 - 12/2009
14
Fluorouracil (Carac)
FDA Link
Generic
01/2021 - 05/2002
12
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 01/2007
12
Progesterone Receptors (Progesterone Receptor)
IBA
10/2020 - 02/2003
10
Capecitabine (Xeloda)
FDA Link
07/2019 - 08/2003
10
Tamoxifen
FDA Link
Generic
01/2016 - 05/2002
9
Estrogens (Estrogen)
FDA Link
01/2019 - 02/2003
8
Taxoids (Taxanes)
IBA
01/2020 - 05/2002
8
Carboplatin (JM8)
FDA Link
Generic
01/2019 - 01/2011
8
Biological Products
IBA
06/2017 - 06/2005
7
Ado-Trastuzumab Emtansine
IBA
02/2022 - 10/2016
7
pertuzumab
IBA
10/2021 - 10/2016
6
Epidermal Growth Factor (EGF)
IBA
10/2020 - 06/2011
6
Proteins (Proteins, Gene)
FDA Link
01/2019 - 09/2004
6
Bevacizumab (Avastin)
FDA Link
04/2017 - 07/2010
6
Pharmaceutical Preparations
IBA
01/2017 - 09/2002
5
DNA (Deoxyribonucleic Acid)
IBA
01/2016 - 01/2008
5
ixabepilone (BMS 247550)
FDA Link
10/2015 - 01/2011
5
Messenger RNA (mRNA)
IBA
01/2013 - 01/2007
4
Epirubicin (Ellence)
FDA Link
Generic
01/2021 - 01/2007
4
Lapatinib (GW572016)
FDA Link
07/2019 - 07/2010
4
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2019 - 01/2008
4
Gemcitabine
FDA Link
01/2018 - 09/2003
4
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2017 - 01/2002
4
Phenobarbital (Luminal)
FDA Link
03/2017 - 05/2009
4
Anastrozole (Arimidex)
FDA Link
Generic
02/2012 - 06/2002
3
RNA (Ribonucleic Acid)
IBA
01/2020 - 01/2015
3
liposomal doxorubicin (Doxil)
FDA Link
04/2017 - 04/2002
3
Selective Estrogen Receptor Modulators (SERM)
IBA
01/2016 - 03/2004
3
Aromatase Inhibitors
IBA
02/2012 - 03/2004
2
Dexamethasone (Maxidex)
FDA Link
Generic
12/2021 - 08/2006
2
Cytokines
IBA
08/2019 - 02/2004
2
Letrozole (Femara)
FDA Link
Generic
07/2019 - 12/2018
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2019 - 07/2009
2
exemestane (Aromasin)
FDA Link
01/2019 - 03/2004
2
N-acetyltalosaminuronic acid (NAT)
IBA
11/2018 - 09/2015
2
tipifarnib (R115777)
IBA
01/2018 - 10/2013
2
Keratins (Keratin)
IBA
12/2016 - 11/2005
2
Indicators and Reagents (Reagents)
IBA
08/2016 - 01/2016
2
Methotrexate (Mexate)
FDA Link
Generic
12/2015 - 03/2010
Therapy/Procedure
75
Therapeutics
01/2022 - 04/2002
67
Drug Therapy (Chemotherapy)
01/2022 - 04/2002
58
Neoadjuvant Therapy
12/2022 - 07/2002
20
Radiotherapy
04/2018 - 07/2002
12
Mastectomy (Mammectomy)
08/2021 - 07/2002
8
Adjuvant Chemotherapy
01/2019 - 05/2002
7
Segmental Mastectomy (Lumpectomy)
04/2018 - 10/2002
5
Aftercare (After-Treatment)
01/2018 - 07/2002
5
Mammaplasty (Breast Reconstruction)
03/2017 - 12/2008
4
Combination Drug Therapy (Combination Chemotherapy)
12/2014 - 04/2010
3
Pancreatectomy
01/2019 - 02/2015
3
Pancreaticoduodenectomy
01/2018 - 02/2016
3
Transplantation
06/2015 - 01/2015
2
Lymph Node Excision (Lymph Node Dissection)
09/2020 - 07/2008
2
Simple Mastectomy
02/2016 - 12/2008